A sample text widget

Etiam pulvinar consectetur dolor sed malesuada. Ut convallis euismod dolor nec pretium. Nunc ut tristique massa.

Nam sodales mi vitae dolor ullamcorper et vulputate enim accumsan. Morbi orci magna, tincidunt vitae molestie nec, molestie at mi. Nulla nulla lorem, suscipit in posuere in, interdum non magna.

Egypt Among The Highest Diabetes Rates in The MENA Region

Egypt has figured within the list of countries with the highest incidence of cases as up to 11 per cent of its population has been diagnosed with the disease, according to a specialized medical study. With current estimates indicating that the number of cases is set to double by 2025, it is crucial for government and key stakeholders in the industry to coordinate and collaborate in launching large-scale awareness campaigns and ensuring the highest level of excellence in the delivery of specialized services. In this context, GlaxoSmithKline (GSK) recently organized a press conference at the Grand Hyatt Cairo to highlight the latest developments and breakthroughs related to strategies and medications for diabetes, a chronic disease that has attracted major attention across Egypt and the rest of the MENA region.

Ashraf Mansour, Medical and Regulatory Director at GlaxoSmithKline, Egypt, said, “Organizing this conference is in line with our aim to create more awareness about the latest medications and best practices in the treatment of diabetes. We also seek to discuss the potential opportunities and challenges during the different stages of treatment and prevention of diabetes, which is very crucial amid the expected significant increase in diabetes incidence in Egypt and the rest of the region. In this regard, we have invited a group of university professors to this conference to discuss effective strategies and medications used in the treatment of diabetes, such as Avandia, which was recommended by the American Diabetes Association as a first-line therapy for all stages of type 2 diabetes.”

“Scientific researches all over the world have proved the effectiveness of Rosiglitazone (Avandia) in controlling the sugar levels for a long time, which is consistent with the strategies of medical associations that recommend maintaining a constant level of sugar over a long period to prevent health complications arising from diabetes. Hence, we reaffirm our commitment to develop new strategies and techniques to improve the quality of and medicines available for diabetes patients, as well as to cooperate with various private and government agencies to launch awareness campaigns about the nature of diabetes and the ways to reduce the incidence of the disease in Egypt,” added Mansour.

GlaxoSmithKline produces different kinds of medicines for the treatment of a wide range of serious diseases such as diabetes, asthma, viral infections, mental health and digestive problems. The company is also the world’s leading manufacturer of vaccines and has been a prominent figure in developing new methods to treat cancer. The company also conducts special researches on medicines and vaccines for three diseases that are of special concern of the World Health Organization (WHO), which are AIDS (Acquired Immunodeficiency Syndrome), tuberculosis and malaria.

VN:F [1.9.22_1171]
Rating: 10.0/10 (1 vote cast)
VN:F [1.9.22_1171]
Rating: 0 (from 0 votes)
Egypt Among The Highest Diabetes Rates in The MENA Region , 10.0 out of 10 based on 1 rating

Leave a Reply

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>